Top Health Care companies in Netherlands by Debt to Equity Ratio
Netherlands
# |
Name |
Debt to Equity Ratio |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
1.23
|
Dec. 31, 2023 | USD 22.92 | 2.26% |
|
Netherlands |
|
| 2 |
0.78
|
Dec. 31, 2023 | USD 9.93 | 5.98% |
|
Netherlands |
|
| 3 |
0.74
|
Dec. 31, 2023 | USD 139.49 | 1.47% |
|
Netherlands |
|
| 4 |
0.67
|
Dec. 31, 2023 | USD 13.23 | -4.06% |
|
Netherlands |
|
| 5 |
0.64
|
Dec. 31, 2023 | USD 24.98 | -2.69% |
|
Netherlands |
|
| 6 |
0.50
|
Dec. 31, 2023 | USD 121.51 | 5.06% |
|
Netherlands |
|
| 7 |
0.48
|
Dec. 31, 2023 | USD 2.26 | -0.44% |
|
Netherlands |
|
| 8 |
0.42
|
Dec. 31, 2023 | USD 45.57 | -0.94% |
|
Netherlands |
|
| 9 |
0.12
|
Dec. 31, 2023 | USD 0.98 | -1.01% |
|
Netherlands |
|
| 10 |
0.03
|
Dec. 31, 2023 | USD 39.01 | -3.56% |
|
Netherlands |
|
| 11 |
0.00
|
Dec. 31, 2023 | USD 673.61 | 1.66% |
|
Netherlands |
|
| 12 |
0.00
|
Dec. 31, 2023 | USD 16.00 | -2.50% |
|
Netherlands |
|
| 13 |
0.00
|
Dec. 31, 2023 | USD 23.67 | -3.70% |
|
Netherlands |
Frequently Asked Questions
-
Which Health Care company in Netherlands has the highest Debt to Equity Ratio ?
The Health Care company in Netherlands with the highest Debt to Equity Ratio is Corbion N.V. (Amsterdam Stock Exchange: CRBN.AS) at 1.23.
-
Which Health Care company in Netherlands has the lowest Debt to Equity Ratio ?
The Health Care company in Netherlands with the lowest Debt to Equity Ratio is NewAmsterdam Pharma Company N.V. (NasdaqGM: NAMS) at 0.00.
-
What are the top 10 Health Care companies in Netherlands by Debt to Equity Ratio ?
The top 10 Health Care companies in Netherlands by Debt to Equity Ratio are Corbion N.V., Pharming Group N.V., IMCD N.V., uniQure N.V., Koninklijke Philips N.V., Redcare Pharmacy NV, ProQR Therapeutics N.V., Qiagen N.V., LAVA Therapeutics N.V. and Merus N.V..
-
What are the bottom 10 Health Care companies in Netherlands by Debt to Equity Ratio ?
The bottom 10 Health Care companies in Netherlands by Debt to Equity Ratio are NewAmsterdam Pharma Company N.V., Pharvaris N.V., argenx SE, Merus N.V., LAVA Therapeutics N.V., Qiagen N.V., ProQR Therapeutics N.V., Redcare Pharmacy NV, Koninklijke Philips N.V. and uniQure N.V..